SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 

EFSA favours essential nutrients in cognitive health claim guidance

By Shane Starling , 18-Jul-2012
Last updated on 18-Jul-2012 at 15:13 GMT2012-07-18T15:13:44Z

Essential nutrients work best in the brain, says EFSA
Essential nutrients work best in the brain, says EFSA

Fresh guidance for cognitive health claims in the European Union has spelled out the preference the bloc’s chief science agency has for health benefits of essential nutrients like vitamins and minerals over other nutrients.

“General claims on the maintenance of (unspecified) functions of the nervous system have been proposed for some essential nutrients. The scientific substantiation of these claims was based on the  well-established biochemical role of such nutrients in neural transmission, or on deficiency symptoms  involving the nervous system,” wrote EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA).

“For non-essential food constituents, claims on the improvement, maintenance or reduced loss of (unspecified) neural, brain or psychological functions in general are not sufficiently defined for a scientific evaluation.”

‘Normal development’ claims were also considered insufficiently defined, in a guidance that also confirmed the agency’s well-known preference for human, intervention trials above other forms of evidence like animal and in vitro research.

The guidance, while not unexpected as it follows from the general thrust of NDA claim opinions issued since 2008, will not please many nutrient suppliers, as it affirms what they consider to be the agency’s bias for vitamins and minerals, although omega-3s have also won brain development claims among infants.

Cognitive claims

The agency’s health claims panel said potential cognitive claim domains included memory, attention and concentration, alertness, learning, intelligence, language, and problem solving.

Typical cognitive performance measuring tests like ‘computerised’ or ‘paper-and-pencil’ tests were accepted but, “the effects observed, and  the repeatability of the results, are important considerations when reviewing the evidence.”

“Measures of the neural activity of the brain (e.g. event-related potentials (ERPs) and functional magnetic resonance imaging) obtained during the performance of a relevant  cognitive task may be used as supportive evidence for the psychometric assessment of cognitive endpoints for the scientific substantiation of health claims on cognitive function.”

Subjects with mild cognitive decline, “without clinical diagnosis of dementia or other psychological or neurological diseases which may be responsible for the impairment” were admissible.

Any extrapolation, for instance from patients with dementia, must be explained including any medication contraindications, and would be considered case-by-case by the panel.

Specific advice was also issued for alertness, attention, memory, mood, stress, anxiety, vision and sleep.

EFSA also issued guidance on 'physical claims'. Look here for coverage of that tomorrow.

We'd like to hear your thoughts on the value of this guidance. Fell free to have your say in the comment box below.

EFSA's mental guidance can be found here.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars